The following best-practice guidelines for the prevention, diagnosis and management of diabetes that have been developed for health professionals by medical experts and researchers. Although this information is accessible to non-experts, they are aimed at the practicing health professional.
General Practice Management of Type 2 Diabetes 2016-18
Supported by – AstraZeneca, Sanofi Diabetes & Cardiovascular, Roche Diabetes Care and Eli Lilly
Absolute Cardiovascular Risk Guidelines
National Evidence Based Guidelines for the Management of Type 2 Diabetes
These Guidelines comprise a suite of Type 2 Diabetes Guidelines developed in 2009 under a funding agreement between the Department of Health and Ageing and the Diabetes Australia Guideline Development Consortium.
The five Guidelines in the series, when combined, present a comprehensive set of evidence-based guidelines for the prevention, diagnosis and management of Type 2 Diabetes.
- National Evidence Based Guideline for Diagnosis, Prevention and Management of Chronic Kidney Disease in Type 2 Diabetes
- National Evidence Based Guideline for Case Detection and Diagnosis of Type 2 Diabetes
- National Evidence Based Guideline for Patient Education in Type 2 Diabetes
- National Evidence Based Guideline for Blood Glucose Control in Type 2 Diabetes
- National Evidence Based Guideline for the Primary Prevention of Type 2 Diabetes
National Evidence Based Guidelines on Prevention, Identification and Management of Foot Complications in Diabetes
Approved by the NHMRC, the full guideline, clinical guide, consumer guides and technical report can be downloaded from the Baker IDI Heart & Diabetes Institute
Outcomes and Indicators for Diabetes Education: National Consensus Position Information and Education for People with Diabetes: a 'Best Practice' Strategy
The Outcomes and Indicators report details a systematically derived framework of nationally agreed goals, outcomes and indicators for diabetes education. It provides a benchmark and policy platform for refining and evaluating the consistency, quality and effectiveness of diabetes education services which can be applied nationally and/or at a regional or local service level.
National Evidence Based Clinical Care Guidelines for Type 1 Diabetes in Children, Adolescents and Adults
The Australian Diabetes Society (ADS) and the Australasian Paediatric Endocrine Group (APEG) have completed the National Evidence Based Clinical Care Guidelines for Type 1 Diabetes in Children, Adolescents and Adults and is approved by the NHMRC under section 14A of the National Health and Medical Research Council Act 1992. The guidelines are available on the Diabetes Society website (scroll down the page).